EMD-62692

Single-particle
2.9 Å
EMD-62692
3D View Gallery
Deposition: 12/12/2024
Map released: 19/03/2025
Last modified: 26/03/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-62692

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-9l09 summary report (pdf.gz) Map-9l09 FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

SARS-CoV-2 C-RTC with 13-TP

EMD-62692

Single-particle
2.9 Å
EMD-62692
3D View Gallery
Deposition: 12/12/2024
Map released: 19/03/2025
Last modified: 26/03/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Severe acute respiratory syndrome coronavirus 2
Sample: SARS-CoV-2 C-RTC with 13-TP
Fitted models: 9l09

Deposition Authors: Huang YC, Liang L, Liu YX, Yan LM, Lou ZY, Rao ZH
Discovery of a 2'-a-Fluoro-2'-b-C-(fluoromethyl) Purine Nucleotide Prodrug as a Potential Oral Anti-SARS-CoV-2 Agent
Liang L, Meng Y, Chang X, Li E, Huang Y, Yan L, Lou Z, Peng Y, Zhu B , Yu W , Chang J
(2025) J Med Chem , 68 , 1994 - 2007
PUBMED: 39804580
DOI: doi:10.1021/acs.jmedchem.4c02769
ISSN: 1520-4804
ASTM: JMCMAR
Grant Support: